J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts
Johnson & Johnson (J&J) has become the latest in a stream of pharma companies to sign a drug pricing deal…
Trump Tariffs
-
-
Eli Lilly picks Alabama as home to $6bn orforglipron manufacturing facility
American pharmaceutical giant Eli Lilly has tapped Huntsville, Alabama, as the location for its third orforglipron manufacturing facility. Set to…
-
UK and US strike “landmark” zero-tariff pharma deal
The UK and US governments have come to an agreement that will see the UK subject to zero tariffs on…
-
Eli Lilly ramps up orforglipron production with $1.2bn Puerto Rico site expansion
Eli Lilly will invest more than $1.2bn into its manufacturing site in Puerto Rico, as the drugmaker looks to assemble…
-
MSD initiates construction on $3bn Virginia drug manufacturing site
Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming…
-
New US biotech hubs show potential amid onshoring requests
The US has always been a key player in the pharmaceutical industry, with prominent names like Pfizer, Eli Lilly and…
-
AstraZeneca inks Trump drug pricing deal amid tariff threats
UK-Swedish pharmaceutical giant AstraZeneca has signed a drug pricing deal with the US government, becoming the second industry titan to…
-
Drugmakers point to US expansion plans amid Trump’s 100% drug tariff
The US will impose a 100% tariff on certain pharma products entering the country, the latest move by the Trump…
-
Business concerns about tariffs continue to rise
Concerns about tariffs among businesses globally have continued to rise significantly over the last six months, according to a new…
-
CapVest to buy control of generics giant Stada in €10bn deal
CapVest Partners has agreed to purchase a majority stake in German generics manufacturer Stada Arzneimittel, marking one of the largest…
